Facing challenges, Deciphera cuts workforce by a third
Deciphera is regrouping after Qinlock failed to outperform standard of care in a Phase 3 study testing the drug as a second-line treatment for GIST. Sales of the drug...
IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.